Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Ingersoll Rand logoIngersoll Rand IR

The company reported revenue of $1,887.9 million ($1,805.3 million a year earlier) for Q2 2025 (3 months), and a net loss attributable to Ingersoll Rand of $115.3 million ($0.29 per share). Adjusted EBITDA was $509.4 million, with a margin of 27.0%.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company reported revenue of $1,887.9 million ($1,805.3 million a year earlier) for Q2 2025 (3 months), and a net loss attributable to Ingersoll Rand of $115.3 million ($0.29 per share). Adjusted EBITDA was $509.4 million, with a margin of 27.0%.

  2. Ingersoll Rand recorded non-cash impairment charges in Q2, with goodwill impairment of $229.7 million and other intangible asset impairment of $36.1 million included in the income statement. The company said the impairments do not affect adjusted earnings or underlying operational performance.

  3. The company said free cash flow was $210 million in Q2, calculated as operating cash flow of $246 million less capital expenditures of $35 million, compared with $283 million in the prior-year period. It returned about $508 million to shareholders in the same quarter, including $500 million in share repurchases and $8 million in dividends.

  4. The company said it is raising its full-year 2025 outlook for revenue, Adjusted EBITDA and Adjusted EPS. Total revenue is expected to grow 4 to 6% year over year, Adjusted EBITDA is expected to be $2,100M to $2,160M (up +4% to +7% year over year), and Adjusted EPS is expected to be $3.34 to $3.46.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Ingersoll Rand Q2 Revenue of $1,887.9 million, Net Loss of $115.3 million

The company reported revenue of $1,887.9 million ($1,805.3 million a year earlier) for Q2 2025 (3 months), and a net loss attributable to Ingersoll Rand of $115.3 million ($0.29 per share). Adjusted EBITDA was $509.4 million, with a margin of 27.0%.

Source · Based on the filing body and exhibits

Ingersoll Rand Records Non-Cash Impairments in Q2

Ingersoll Rand recorded non-cash impairment charges in Q2, with goodwill impairment of $229.7 million and other intangible asset impairment of $36.1 million included in the income statement. The company said the impairments do not affect adjusted earnings or underlying operational performance.

Source · Based on the filing body and exhibits

Ingersoll Rand Free Cash Flow and Shareholder Returns in Q2

The company said free cash flow was $210 million in Q2, calculated as operating cash flow of $246 million less capital expenditures of $35 million, compared with $283 million in the prior-year period. It returned about $508 million to shareholders in the same quarter, including $500 million in share repurchases and $8 million in dividends.

Source · Based on the filing body and exhibits

Ingersoll Rand Raises Full-Year 2025 Outlook

The company said it is raising its full-year 2025 outlook for revenue, Adjusted EBITDA and Adjusted EPS. Total revenue is expected to grow 4 to 6% year over year, Adjusted EBITDA is expected to be $2,100M to $2,160M (up +4% to +7% year over year), and Adjusted EPS is expected to be $3.34 to $3.46.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.